Recent research suggests that Sacubitril/Valsartan may enhance treatment outcomes for diabetic cardiomyopathy by modulating the immune response to inflammation. Diabetic cardiomyopathy is a condition characterized by structural and functional changes in the heart muscle due to diabetes. The study explores how the combination of Sacubitril and Valsartan influences the immune system’s response to inflammation, potentially […]